Post-treatment, patients may experience a variety of temporary symptoms such as fatigue, upset stomach, headaches, dizziness, or feeling gassy/bloated
Tirzepatide is a dual GIP/GLP-1 receptor agonist, while Retatrutide (LY3437943) adds a third target the glucagon receptor making it a triple agonist studied for broader metabolic effects
And you have enough data about your postpartum baseline, including energy levels, mood stability, and sleep patterns, to make an informed decision about adding a new medication
(ODS 2023) In the context of cancer, supplementation with LC has been claimed to protect organs from chemo- and radiotherapy-related toxicities, to alleviate cancer-related fatigue and cancer anorexia-cachexia syndrome
Additionally, local support groups or nutritionists can offer complementary guidance to enhance your weight loss journey and manage any challenges